| 今开：3.71 | 昨收：3.69 |
| 最高：3.72 | 最低：3.6523 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：3.12250462E8 |
Atea(AVIR)02-15 22:25
$Atea(AVIR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000207 Act: 34 Size: 47 KB 网页链接查看全文
Atea(AVIR)02-03 10:35
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-010970 Size: 10 KB 网页链接查看全文
Atea(AVIR)02-29 05:35
$Atea(AVIR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-050724 Act: 34 Size: 220 KB 网页链接查看全文
Atea(AVIR)02-07 22:35
$Atea(AVIR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001616824-24-000017 Act: 34 Size: 83 KB 网页链接查看全文
Atea(AVIR)02-03 10:35
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-010972 Size: 11 KB 网页链接查看全文
Atea(AVIR)02-02 05:25
$Atea(AVIR)$ 144 Report of proposed sale of securities Accession Number: 0000950170-24-009804 Act: 33 Size: 4 KB 网页链接查看全文
Atea(AVIR)02-02 05:25
$Atea(AVIR)$ 144 Report of proposed sale of securities Accession Number: 0000950170-24-009799 Act: 33 Size: 4 KB 网页链接查看全文
Atea(AVIR)02-03 10:35
$Atea(AVIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-010969 Size: 10 KB 网页链接查看全文
Atea(AVIR)02-07 22:25
$Atea(AVIR)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001616824-24-000015 Act: 34 Size: 83 KB 网页链接查看全文
Atea(AVIR)02-14 05:35
$Atea(AVIR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-033799 Act: 34 Size: 58 KB 网页链接查看全文
智通财经APP获悉，摩根大通分析师Eric Joseph将Atea Pharmaceuticals(AVIR.US)的评级从“增持”下调至“中性”，并将其目标价从61美元下调至16美元。 据悉，Atea Pharmaceuticals周二表示，其研制的AT-527型口服新冠药物未能通过一项关... 网页链接
智通财经APP获悉，美东时间10月19日(周二)盘后，截至发稿，临床阶段生物制药公司Atea Pharmaceuticals(AVIR.US)涨超3%，此前该股收跌65.96%，报13.82美元。据悉，Atea Pharmaceuticals周二表示，其研制的AT-527型口服新冠药物未能通过一... 网页链接
生物制药公司Atea Pharmaceuticals， Inc。(AVIR.O)盘前大涨44%，此前默沙东(MRK.N)及其合作伙伴Ridgeback公布了其治疗新冠病毒药物的中期数据。 网页链接
美国卫生和公共服务部发表声明，美国政府将投资32亿美元开发针对Covid-19的抗病毒药物。 一些药物可能在年底前上市。 政府正在考虑Atea Pharmaceuticals开发的AT-527。 Atea股价周四一度上涨13.6%。 辉瑞科学家... 网页链接
$Atea(AVIR)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-049220 Act: 34 Size: 1 MB 网页链接
$Atea(AVIR)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-049178 Act: 34 Size: 5 MB 网页链接
$Atea(AVIR)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-022226 Act: 34 Size: 12 MB 网页链接
$Atea(AVIR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-24-050724 Act: 34 Size: 220 KB 网页链接
$Atea(AVIR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000226 Act: 34 Size: 47 KB 网页链接
$Atea(AVIR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000207 Act: 34 Size: 47 KB 网页链接
$Atea(AVIR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-24-000228 Act: 34 Size: 45 KB 网页链接
$Atea(AVIR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-020352 Act: 34 Size: 13 KB 网页链接
$Atea(AVIR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-24-033799 Act: 34 Size: 58 KB 网页链接
$Atea(AVIR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000315066-24-000968 Act: 34 Size: 8 KB 网页链接